drugset / Trial / NCT00834704
Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors
Non-randomizedSingle-groupOpen-label
Summary
Open-label, multicenter, dose-escalation, safety, pharmacodynamic, and pharmacokinetic study.
Timeline
- Start
- 2009-02
- Primary completion
- 2012-06
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegvorhyaluronidase Alfa | Protein / enzyme biologic | — | Intravenous |